The FDA Approval of Lechemby for Alzheimer's Disease

Lechemby is the first drug proven to actually slow down the course of Alzheimer's disease. The FDA included a recommendation and not a requirement that patients who might receive this drug get genetic testing before receiving it. That recommendation, which we were talking to a funeral just who intend to follow it for purposes of safety, I also don't think will necessarily be a barrier to prescriptions of Le Tembi. What it really just does is adds to the hurdles that have to be cleared before a patient can actually get this drug.